All Stories

  1. Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis

    Article • Drug Design Development and Therapy, November 2018, Dove Medical Press

    Alan Menter MD, Isabel Haugh

  2. Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinib

    Article • Baylor University Medical Center Proceedings, September 2018, Taylor & Francis

    Isabel Haugh, Alan Menter MD